Symbiotec Pharmalab Ltd. IPO Details

Symbiotec Pharmalab was incorporated on September 20, 2002. The company is an R&D-driven;, science-based pharmaceutical and biotechnology player with capabilities in organic chemistry, biotechnology, and complex injectables, and a global leadership position in corticosteroid and steroidal-hormone APIs. It is the only Indian and global company present across the top 10 such APIs in FY25, manufacturing them through fermentation and complex multi-step chemical processes